Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Current Deferred Revenue (2023 - 2025)

Cannabis Bioscience International Holdings' Current Deferred Revenue history spans 2 years, with the latest figure at $12000.0 for Q3 2025.

  • For Q3 2025, Current Deferred Revenue changed N/A year-over-year to $12000.0; the TTM value through Aug 2025 reached $12000.0, changed N/A, while the annual FY2023 figure was $28641.0, N/A changed from the prior year.
  • Current Deferred Revenue for Q3 2025 was $12000.0 at Cannabis Bioscience International Holdings, down from $28641.0 in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $28641.0 in Q2 2023 and bottomed at $12000.0 in Q3 2025.